SCHEMBL1090106

SCHEMBL1090106

O=C(NCCNc1nccc(N2CCCCCC2)n1)C1CCCCC1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 2/20 0.58
GPBAR1 Q8TDU6 3/20 0.48
ALK Q9UM73 6/20 0.47
HRH4 Q9H3N8 4/20 0.46
MRGPRX1 Q96LB2 1/20 0.46
OGA O60502 1/20 0.45
IGF1R P08069 2/20 0.45
SHMT2 P34897 1/20 0.44
CKS1B P61024 1/20 0.44
SKP1 P63208 1/20 0.44
SKP2 Q13309 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
STK17B O94768 1/20 0.44
TYK2 P29597 1/20 0.44
AAK1 Q2M2I8 1/20 0.44
SIK2 Q9H0K1 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
STK17A Q9UEE5 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1089291 0.83 CXCR4 (0.64) CXCR4HRH4MRGPRX1OGAHRH3
SCHEMBL1088913 0.82 CXCR4 (0.54) CXCR4HRH4MRGPRX1OGAHRH3
SCHEMBL1090759 0.80 CXCR4 (0.60) CXCR4HRH4MRGPRX1OGAHRH3
SCHEMBL1091026 0.79 CXCR4 (0.58) CXCR4HRH4MRGPRX1OGAHRH3
Hydrochloric Acid SCHEMBL1090184 0.77 CXCR4 (0.66) CXCR4HRH4MRGPRX1OGAHRH3
SCHEMBL1090274 0.76 CXCR4 (0.55) CXCR4HRH4MRGPRX1OGAHRH3
SCHEMBL2074799 0.74 HRH4 (0.46) CXCR4ALKHRH4IGF1RSHMT2
SCHEMBL1090046 0.74 CXCR4 (1.00) CXCR4HRH4MRGPRX1OGAHRH3
SCHEMBL1089904 0.74 CXCR4 (1.00) CXCR4HRH4MRGPRX1OGAHRH3
SCHEMBL1090583 0.74 CXCR4 (0.74) CXCR4HRH4MRGPRX1OGAHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885GPBAR1 922/4885ALK 882/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 CXCR4 1/4885GPBAR1 922/4885ALK 882/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 CXCR4 1/4885GPBAR1 922/4885ALK 882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.